- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
Fischer Medical Ventures' Board has approved the financial results for the quarter ended June 30, 2025. Consolidated revenue from operations stood at 49.17 Cr, with a profit of 1.31 Cr. Standalone revenue was 4.54 Cr, resulting in a loss of 0.61 Cr. The 32nd Annual General Meeting will be held on September 29 via video conferencing. The company also appointed M/s Nuren Lodaya & Associates as Scrutinizer for the AGM e-voting and endorsed their appointment as Secretarial Auditors for five years. Dr. Jacob Thomas, an Independent Director, resigned.